An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress

NCT02498392 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder
Anxiety

Interventions

DRUG: JNJ-42165279
OTHER: Placebo

Sponsor

Janssen Research & Development, LLC